| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| NVS | Novartis AG | $85.13 | $197.65B | Sell |
Top Gene-Sequencing Stocks for 2019
https://www.fool.com/investing/2019/04/19/top-gene-sequencing-stocks-for-2019.aspx?source=iedfolrf0000001
Apr 19, 2019 - These next-generation companies are working on game-changing ways to obtain and profit from genetic insight.
0
3 Top Dividend Stocks to Buy Right Now
https://www.fool.com/investing/2019/04/19/3-top-dividend-stocks-to-buy-right-now.aspx?source=iedfolrf0000001
Apr 19, 2019 - Sometimes you have to act while the iron's hot, and that's the case with these three big-name dividend payers right now.
0
Schlumberger NV (SLB) Q1 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2019/04/18/schlumberger-nv-slb-q1-2019-earnings-call-transcri.aspx?source=iedfolrf0000001
Apr 18, 2019 - SLB earnings call for the period ending March 31, 2019.
0
Valicenti Advisory Services Inc Buys LyondellBasell Industries NV, CVS Health Corp, Discover ...
http://www.gurufocus.com/news/857175/valicenti-advisory-services-inc-buys-lyondellbasell-industries-nv-cvs-health-corp-discover-financial-services-sells-fedex-corp-invesco-sp-500-equal-weight-technology-rio-tinto-plc
Apr 18, 2019 - Valicenti Advisory Services Inc Buys LyondellBasell Industries NV, CVS Health Corp, Discover Financial Services, Sells FedEx Corp, Invesco S&P 500 Equal Weight Technology, Rio Tinto PLC, Stocks: CVS,DFS,LYB,XLE,XLK,RYT,FDX,RIO,BSCK,PK,BRKR,, release date:Apr 18, 2019
0
Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs
http://www.zacks.com/stock/news/386875/roches-rhhby-q1-sales-strong-on-solid-demand-for-new-drugs?cid=CS-ZC-FT-386875
Apr 18, 2019 - Roche's (RHHBY) performance in the first quarter of 2019 is driven by solid strength of new drugs, which more than offset competition from biosimilars.
0
TomTom NV (TMOAF) CEO Harold Goddijn on Q1 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4254966-tomtom-nv-tmoaf-ceo-harold-goddijn-q1-2019-results-earnings-call-transcript?source=feed_sector_transcripts
Apr 17, 2019 - TomTom NV (OTCPK:TMOAF) Q1 2019 Earnings Conference Call April 17, 2019, 08:00 ET Company Participants Bruno Priuli - IR Officer Harold Goddijn - Co-Founder, Chairman & CEO Taco Titulaer - CFO Con
0
Alnylam Initiates Phase III ILLUMINATE-B Study on Lumasiran
http://www.zacks.com/stock/news/382387/alnylam-initiates-phase-iii-illuminate-b-study-on-lumasiran?cid=CS-ZC-FT-382387
Apr 16, 2019 - Alnylam (ALNY) initiates phase III study on lumasiran and also reports new positive efficacy results from the ongoing phase II open-label extension (OLE) study on the same.
0
Novartis' (NVS) BLA for Ophthalmology Drug Accepted by FDA
http://www.zacks.com/stock/news/382060/novartis-nvs-bla-for-ophthalmology-drug-accepted-by-fda?cid=CS-ZC-FT-382060
Apr 16, 2019 - The FDA accepts Novartis' (NVS) BLA seeking approval for brolucizumab for the treatment of wet AMD.
0
Are You Looking for a High-Growth Dividend Stock? Ahold NV (ADRNY) Could Be a Great Choice
http://www.zacks.com/stock/news/381329/are-you-looking-for-a-high-growth-dividend-stock-ahold-nv-adrny-could-be-a-great-choice?cid=CS-ZC-FT-381329
Apr 16, 2019 - Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Ahold NV (ADRNY) have what it takes? Let's find out.
0
Alnylam (ALNY) Reports Phase III ENVISION Data on Givosiran
http://www.zacks.com/stock/news/381022/alnylam-alny-reports-phase-iii-envision-data-on-givosiran?cid=CS-ZC-FT-381022
Apr 15, 2019 - Alnylam (ALNY) reports complete positive results from the phase III ENVISION study of givosiran for the treatment of acute hepatic porphyria.
0
Page 1>